Comments on "a new view of diabetic Retinopathy" by A.J. Barber (multiple letters)

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 4, 2004, Pages 747-748

  Arden, G B ^a   Barber, Alistair J ^b  

^a CITY UNIVERSITY   (United Kingdom)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; NEUROTRANSMITTER RECEPTOR; PHOSPHOTRANSFERASE; VASCULOTROPIN;

APOPTOSIS; BLOOD VESSEL PERMEABILITY; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; DEMENTIA; DIABETIC RETINOPATHY; ELECTROPHYSIOLOGY; HUMAN; LETTER; MUELLER CELL; NERVE CELL; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; OXYGEN TENSION; PERIPHERAL NERVOUS SYSTEM; PHOTORECEPTOR; PROTEIN EXPRESSION; RETINA; RETINA CELL; RISK ASSESSMENT; SECOND MESSENGER; STROKE; DEGENERATIVE DISEASE; NOTE; OXYGEN CONSUMPTION; PATHOLOGY; PHYSIOLOGY;

DIABETIC RETINOPATHY; HUMANS; NEURODEGENERATIVE DISEASES; OXYGEN CONSUMPTION; PHOTORECEPTORS, VERTEBRATE; RETINA;

EID: 3342907984     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.02.001     Document Type: Letter

References (13)

1. R.H. Amin R.N. Frank A. Kennedy D. Elliot J.E. Puklin G.W. Abrams Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with non-proliferative diabetic retinopathy Invest. Ophthalmol. Visual Sci. 38 1997 36 47
2. G.B. Arden The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment Br. J. Ophthalmol. 85 2001 366 370
3. A.J. Barber A new view of diabetic retinopathy: a neurodegenerative disease of the eye Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 2003 283 290
4. Chibber et al.,2003. Submitted.
5. F.M. Dean G.B. Arden A. Dornhorst Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects Br. J. Ophthalmol. 81 1997 27 30
6. N. Drasdo Z. Chiti D.R. Owens R.V. North Effect of darkness on inner retinal hypoxia in diabetes Lancet 359 9325 2002 2251 2253 (Jun 29)
7. T.S. Kern R.L. Engerman Capillary lesions develop in retina rather than in cerebral cortex in diabetes and experimental galactosaemia Arch. Ophthalmol. 114 1996 306 310
8. J. Lahdenranta An anti-angiogenic state in mice and humans with retinal photoreceptor degeneration Proc. Natl. Acad. Sci. U. S. A. 98 2001 10368 10373
9. D. Lambrechts E. Storkebaum M. Morimoto VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat. Genet. 34 2003 357 358
10. Q. Li E. Zemmel B. Miller I. Perlman Early retinal damage in experimental diabetes: electroretinographical and morphological observations Exp. Eye Res. 74 2002 615 625
11. S. Marsh F.M. Nakhoul K. Skorecki A. Rubin B.P. Miller R. Leibu N.S. Levy A.P. Levy Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy Diabetes Care 23 2000 1375 1380
12. E. Runger-Brandle A.A. Dosso P.M. Leuenberger Glial reactivity, an early feature of diabetic retinopathy Invest. Ophthalmol. Visual Sci. 41 2000 1971 1980
13. A.N. Witmer G.F. Vrensen C.J. Van Noorden R.O. Schlingemann Vascular endothelial growth factors and angiogenesis in eye disease Prog. Retin. Eye Res. 22 2003 1 29